Conformis, Inc. (CFMS) News
Filter CFMS News Items
CFMS News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CFMS News Highlights
- For CFMS, its 30 day story count is now at 3.
- Over the past 15 days, the trend for CFMS's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest CFMS News From Around the Web
Below are the latest news stories about CONFORMIS INC that investors may wish to consider to help them evaluate CFMS as an investment opportunity.
restor3d Completes Acquisition of ConformisCombination Creates the World’s Preeminent Producer of Personalized Orthopedic Medical Devices, with Unmatched Additive Manufacturing CapabilitiesDURHAM, North Carolina and BILLERICA, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- restor3d, Inc. and Conformis, Inc. announced today that restor3d has completed its previously announced acquisition of Conformis following the approval of Conformis’ stockholders at a special meeting held on August 31, 2023. In connection with the completion of the acquisit |
Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Conformis Stockholders Vote “FOR” the Pending Merger with restor3dBILLERICA, Mass., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, announced today that leading independent proxy advisory firms, Institutional Shareholder Services Inc. (“ISS”) and Glass Lewis & Co., LLC (“Glass Lewis”), have each recommended that Conformis stockholders vote “FOR” the pending merger transaction with restor3d. As previously announced, under the terms of the definitive m |
Independent Proxy Advisory Firm ISS Recommends Conformis Stockholders Vote “FOR” the Pending Merger with restor3dBILLERICA, Mass., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, announced today that leading independent proxy advisory firm, Institutional Shareholder Services Inc. (“ISS”), has recommended that Conformis stockholders vote “FOR” the pending merger transaction with restor3d. As previously announced, under the terms of the definitive merger agreement, restor3d will acquire all outstan |
ConforMIS (CFMS) Reports Q2 Loss, Tops Revenue EstimatesConforMIS (CFMS) delivered earnings and revenue surprises of -34.85% and 2.71%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? |
Conformis Reports Second Quarter 2023 Financial ResultsBILLERICA, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Summary Total revenue of $13.0 million, a decrease of 15% year-over-year on a reported and constant currency basis.Product revenue of $12.5 million, a decrease of 17% year-over-year on a reported and constant currency ba |
There's No Escaping Conformis, Inc.'s (NASDAQ:CFMS) Muted Revenues Despite A 86% Share Price RiseConformis, Inc. ( NASDAQ:CFMS ) shareholders would be excited to see that the share price has had a great month... |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayIt's time for a final dive into the biggest pre-market stock movers this week as we check out what's happening on Friday! |
Conformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in CashCombination creates a leading personalized 3D-printed orthopedic medical device companyDURHAM, N.C. and BILLERICA, Mass., June 22, 2023 (GLOBE NEWSWIRE) -- restor3d, Inc. and Conformis, Inc. (NASDAQ: CFMS) announced today that they have entered into a definitive merger agreement under which restor3d, a leading personalized 3D-printed orthopedic company, will acquire all outstanding shares of common stock of Conformis at $2.27 per share in cash, which represents an approximate 96 percent premium |
Conformis, Inc. (NASDAQ:CFMS) Q1 2023 Earnings Call TranscriptConformis, Inc. (NASDAQ:CFMS) Q1 2023 Earnings Call Transcript May 8, 2023 Conformis, Inc. beats earnings expectations. Reported EPS is $-1.32, expectations were $-1.39. Operator: Good morning, and welcome to the First Quarter 2023 Earnings Conference Call for Conformis, Incorporated. My name is Tanya, and I will be your conference operator today. All lines have been […] |
ConforMIS (CFMS) Reports Q1 Loss, Tops Revenue EstimatesConforMIS (CFMS) delivered earnings and revenue surprises of 15.38% and 2.37%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock? |